Following the increased understanding of the disease, new immunotherapies were developed (COPAXON /; Interferon -beta )in the last 10-15 years for long term treatment. However these can attenuate the disease (reduce the number of relapses per year) but do not cure it. In addition, they are beneficial in only ~40 % of the Relapsing -Remitting patients. Currently there are no treatments for patients with the Progressive Disease - who have gradual increased disability (Murray 2006).